Monopar Therapeutics

MNPR

Market cap $494M

Overview Fund Trends Analyst Outlook Journalist POV

Buy

Hold

Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$106

32% upside

High target

9 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Barclays Etzer Darout 0% 1-yr MNPR win rate				13 Oct ‘25 6 days ago
Raymond James Chris Raymond 67% 1-yr MNPR win rate				6 Oct ‘25 13 days ago
Oppenheimer Andreas Argyrides 50% 1-yr MNPR win rate				2 Oct ‘25 17 days ago
HC Wainwright & Co Andres Maldonado 100% 1-yr MNPR win rate				29 Sep ‘25 20 days ago
Piper Sandler Biren Amin 100% 1-yr MNPR win rate				25 Sep ‘25 24 days ago
BTIG Jeet Mukherjee 100% 1-yr MNPR win rate				25 Sep ‘25 24 days ago
Chardan Capital Keay Nakae 100% 1-yr MNPR win rate				25 Sep ‘25 24 days ago
Lake Street Chad Messer 100% 1-yr MNPR win rate				23 Sep ‘25 26 days ago
Cantor Fitzgerald Kristen Kluska 50% 1-yr MNPR win rate				27 Aug ‘25 1 month ago